Headlines

BioMedNewsBreaks

BioMedNewsBreaks — Polyrizon Ltd. (NASDAQ: PLRZ) Closes $3.5 Million Registered Direct Offering and Concurrent Private Placement 
Polyrizon Ltd. (PLRZ)
April 15, 2026
BioMedNewsBreaks — MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Engages Venture Liquidity Providers for Market-Making Services 
MindBio Therapeutics Corp. (MBQIF)
April 15, 2026
BioMedNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms NRx Defense Systems Subsidiary to Advance Neuroplastic Therapies for Military and Government Applications
NRx Pharmaceuticals, Inc. (NRXP)
April 15, 2026
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Launches Proposed Public Offering to Support Commercialization and AI Initiatives
HeartBeam Inc. (BEAT)
April 15, 2026
BioMedNewsBreaks — Soligenix Inc. (NASDAQ: SNGX) Showcased for Smarter Path to Drug Development
Soligenix Inc. (SNGX)
April 14, 2026
View More BioMedNewsBreaks

BioMedWire Articles

Compact Proton Therapy Delivery Helps Make the Treatment More Accessible for Cancer Patients
Lixte Biotechnology Holdings, Inc. (LIXT)
April 15, 2026
Soligenix Inc. (NASDAQ: SNGX) Gains Analytical Validation as Pipeline Progress Drives Forward Outlook
Soligenix Inc. (SNGX)
April 15, 2026
Preclinical Study Reveals Promising Treatment for Glioblastoma
CNS Pharmaceuticals Inc. (CNSP)
April 14, 2026
MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Offers World’s First Voice-Enabled AI-Powered Drug and Alcohol Platform for Workplace Substance Abuse Screening
MindBio Therapeutics Corp. (MBQIF)
April 13, 2026
Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA
Calidi Biotherapeutics Inc. (CLDI)
April 10, 2026
View All BioMedWire Articles

Public Press Releases

Filter Releases
Filters
Sector



Remove All Filters
Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
Load More

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000

BioMedWire
BioMedWire

1108 Lavaca St
Suite 110-BMW
Austin, TX 78701
(512) 354-7000

Company Search
Get Quote
Site Search

Copyright © . BioMedWire / 1108 Lavaca St Suite 110-BMW Austin, TX 78701 (512) 354-7000 / Disclaimers